Partial N-gene target failure in the Seegene Allplex SARS-CoV-2 Master Assay as a proxy of SARS-CoV-2 BA.2.86

Antzeko izenburuak

• Evaluation of the Allplex HPV assay’s adherence to international guidelines for cervical cancer screening in clinician-collected samples
  nork: Pui Yan Jenny Chung, et al.
  Argitaratua: (2024-08-01)
• Multicentric Evaluation of SeeGene Allplex Real-Time PCR Assays Targeting 28 Bacterial, Microsporidal and Parasitic Nucleic Acid Sequences in Human Stool Samples
  nork: Felix Weinreich, et al.
  Argitaratua: (2022-04-01)
• Prediction of antimicrobial susceptibility of pneumococci based on whole-genome sequencing data: a direct comparison of two genomic tools to conventional antimicrobial susceptibility testing
  nork: Gerardo J. Sanchez, et al.
  Argitaratua: (2025-02-01)
• Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples
  nork: Margo Bell, et al.
  Argitaratua: (2023-08-01)
• Partial N-gene target failure in the Seegene Allplex SARS-CoV-2 Master Assay as a proxy of SARS-CoV-2 BA.2.86
  nork: Maria Beatrice Valli, et al.
  Argitaratua: (2024-06-01)